Difference between revisions of "Chou 2015 Fatty Acid Oxidation O2k-Network Discussion Forum"
From Bioblast
(Created page with "{{Abstract |title=Chou 2015 Fatty Acid Oxidation O2k-Network Discussion Forum |info=[http://www.bioblast.at/index.php/Talk:Fatty_acid_oxidation O2k-Network Discussion Forum] |aut...") |
Beno Marija (talk | contribs) |
||
| (8 intermediate revisions by 3 users not shown) | |||
| Line 5: | Line 5: | ||
|year=2015 | |year=2015 | ||
|event=Fatty Acid Oxidation O2k-Network Discussion Forum | |event=Fatty Acid Oxidation O2k-Network Discussion Forum | ||
|abstract= | |abstract='''Protocol''': final concentration of digitonin in chamber is 10μg/ml | ||
cell number in chamber is 2 millions cell/ml, cell type PBMC, Malate (2mM), Palmitoyl-DLcarnitine-HCl (20μM), ADP (2.5mM), pyruvate (5mM), glutamate (10mM), succinate (10mM), rotenone (0.1μM), malonic acid(5mM), myxothiazol (0.5μM), antimycin A (2.5μM), TMPD (0.5mM), azide (100mM) | |||
|keywords=PBMC | |||
}} | }} | ||
{{Labeling | {{Labeling | ||
| | |tissues=Blood cells, Lymphocyte, Platelet | ||
|additional=Palmitoylcarnitine | |preparations=Permeabilized cells, Permeabilized tissue | ||
|couplingstates=OXPHOS, ET | |||
|pathways=F, N, S, NS, ROX | |||
|additional=Palmitoylcarnitine, TW, | |||
}} | }} | ||
Latest revision as of 17:33, 25 February 2020
| Chou 2015 Fatty Acid Oxidation O2k-Network Discussion Forum |
Link: O2k-Network Discussion Forum
Chou Cheng-Hsien (2015)
Event: Fatty Acid Oxidation O2k-Network Discussion Forum
Protocol: final concentration of digitonin in chamber is 10μg/ml cell number in chamber is 2 millions cell/ml, cell type PBMC, Malate (2mM), Palmitoyl-DLcarnitine-HCl (20μM), ADP (2.5mM), pyruvate (5mM), glutamate (10mM), succinate (10mM), rotenone (0.1μM), malonic acid(5mM), myxothiazol (0.5μM), antimycin A (2.5μM), TMPD (0.5mM), azide (100mM)
• Keywords: PBMC
Labels:
Tissue;cell: Blood cells, Lymphocyte, Platelet Preparation: Permeabilized cells, Permeabilized tissue
Coupling state: OXPHOS, ET
Pathway: F, N, S, NS, ROX
Palmitoylcarnitine, TW
